Ignite Creation Date:
2024-10-25 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06621381
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-09
Brief Title:
Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Single Group Evaluation of Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the preliminary outcomes of concentrated exposure and response prevention for children with obsessive-compulsive disorder OCD in regular clinical practice It is a non-randomised open label evaluation where children 6-12 years with OCD who are patients at the Child and Adolescent Psychiatry CAP at Uppsala University Hospital will be rectruited together with their legal guardians The treatment will be delivered by trained therapists in regular outpatient care
The main question the study aims to answer is
What are the preliminary treatment effects of concentrated exposure and response prevention with regards to OCD-symptoms functional impact family accomodation and clinician ratings of severity and improvement
Participants will receive psychoeducation in group format and exposure and response prevention 9-12h concentrated to one week individual format
Outcomes will be measured on structured interviews clinician ratings and validated questionnaires pre-treatment post-treatment and at a six month follow-up
The main question the study aims to answer is
What are the preliminary treatment effects of concentrated exposure and response prevention with regards to OCD-symptoms functional impact family accomodation and clinician ratings of severity and improvement
Participants will receive psychoeducation in group format and exposure and response prevention 9-12h concentrated to one week individual format
Outcomes will be measured on structured interviews clinician ratings and validated questionnaires pre-treatment post-treatment and at a six month follow-up
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None